FAI, seen commonly and often caused by aging and ovarian dysfunction, still presents a challenge to clinicians because of some unresolved and unattended aspects of the condition, including standardized diagnosis and management. Although the use of androgens in women who have FAI has been shown to be effective, there are no FDA approved androgen preparations available at this time for women. Large scale, long-term, controlled trials focusing on establishment of valid and standardized diagnosis and treatment options are needed.
|Original language||English (US)|
|Number of pages||10|
|Journal||Obstetrics and Gynecology Clinics of North America|
|State||Published - Dec 1 2006|
All Science Journal Classification (ASJC) codes
- Obstetrics and Gynecology